IPO registrations (S-1, F-1) · Registrants

Aspira Women's Health Inc.

SEC CIK

926617 · filings on EDGAR ↗

Former names

VERMILLION, INC. (2007–2020); CIPHERGEN BIOSYSTEMS INC (2000–2007)

Registration

Form S-1, first filed 2000-03-20, last 2025-12-31; 8 initial registrations, 16 amendments

Outcome

Final prospectus filed 2000-09-29; declared effective 2007-01-19; withdrawal requested 2025-02-13

Industry (SIC)

In Vitro & In Vivo Diagnostic Substances 2835

Incorporated in

DE

Business address

12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, Austin, TX 78738

EIN

33-0595156

Ticker

AWHL (OTC)

EDGAR entity type

operating

Insiders and CEO pay

Aspira Women's Health Inc. on the corporate pages

Offering terms

Proposed price range

$14.00–$16.00 per share (S-1/A filed 2000-09-28)

Final price

$16.00 per share, within the range (424B1 filed 2000-09-29, an initial public offering)

Shares sold

5,500,000

Gross proceeds

$88,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol CIPH

Lead underwriters

Cowen

Syndicate

ING; UBS (1,102,000); ING Barings LLC (1,102,000); Hambrecht & Quist (78,000); CIBC World Markets (78,000); RBC Capital Markets (78,000); Deutsche Bank (78,000); Donaldson, Lufkin & Jenrette (78,000); A.G. Edwards (78,000); Lehman Brothers (78,000); Piper Sandler (78,000); Thomas Weisel Partners (78,000); Crowell, Weedon & Co (39,000); Dominick & Dominick LLC (39,000); Fahnestock & Co. Inc (39,000); Gerard Klauer Mattison & Co., Inc (39,000); Gruntal & Co., L.L.C (39,000); Janney Montgomery Scott (39,000); Morgan Keegan (39,000); Raymond James (39,000); Truist Securities (39,000); Sutro & Co. Incorporated (39,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: ASPIRA WOMEN'S HEALTH INC. EXACT (EIN (EXACT, as the state registration reports it))
• Business registration: ASPIRA WOMEN'S HEALTH INC. Fuzzy (name and state)
• Business registration: ASPIRA WOMEN'S HEALTH INC. Fuzzy (name and state)
• Form 5500 plan sponsor: ASPIRA WOMENS HEALTH, INC. EXACT (EIN (EXACT))
• Form D issuer: Aspira Women's Health Inc. EXACT (CIK (EXACT))
• SEC filer: Aspira Women's Health Inc. EXACT (CIK (EXACT))

Filings 48

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry In Vitro & In Vivo Diagnostic Substances, TX first:

• Anbio Biotechnology 2M
• Asep Medical Holdings Inc. A1
• DNA Testing Centers Corp A6
• NYMOX PHARMACEUTICAL CORP A8
• MABCURE INC. B9
• ANSYS DIAGNOSTICS INC CA
• Monogram Biosciences, Inc. CA
• ARGONAUT TECHNOLOGIES INC CA
• GENENCOR INTERNATIONAL INC CA
• Intuity Medical, Inc. CA

More with this interest.

In other datasets, the same topic (Health) in TX:

• Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))

Interests: In Vitro & In Vivo Diagnostic Substances · Health